Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Layese

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Journal of Hepatology|December 1, 2016
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCCAndrea Notarpaolo, Richard Layese, Paolo Magistri, et al.
Lancet (London, England)|January 23, 2022
An educational programme in neonatal intensive care units (SEPREVEN): a stepped-wedge, cluster-randomised controlled trialLaurence Caeymaex, Dominique Astruc, Valérie Biran, et al.
Immunity & Ageing : I & A|December 28, 2024
CD57<sup>+</sup> EMRA CD8<sup>+</sup> T cells in cancer patients over 70: associations with prior chemotherapy and response to anti-PD-1/PD-L1 therapyCécile Gonnin, Michelle Leemans, Florence Canoui-Poitrine, et al.
American Journal of Hematology|September 7, 2019
Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-rituxSamuel Deshayes, Mehdi Khellaf, Anissa Zarour, et al.
European Heart Journal. Acute Cardiovascular Care|October 11, 2021
Diuretic vs. placebo in intermediate-risk acute pulmonary embolism: a randomized clinical trialPascal Lim, Clément Delmas, Olivier Sanchez, et al.
Intensive Care Medicine|August 22, 2018
Clinical spectrum and short-term outcome of adult patients with purpura fulminans: a French multicenter retrospective cohort studyDamien Contou, Romain Sonneville, Florence Canoui-Poitrine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2018
Long-term Quality of Life in Adult Patients Surviving Purpura Fulminans: An Exposed-Unexposed Multicenter Cohort StudyDamien Contou, Florence Canoui-Poitrine, Rémi Coudroy, et al.
Journal of Viral Hepatitis|November 1, 2018
Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohortSegolene Brichler, Pierre Nahon, Fabien Zoulim, et al.
Journal of Hepatology|July 3, 2020
Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV statusEtienne Audureau, Fabrice Carrat, Richard Layese, et al.
Hepatology (Baltimore, Md.)|June 28, 2016
Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir)Nathalie Ganne-Carrié, Richard Layese, Valérie Bourcier, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Hepatology|December 1, 2016
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCCAndrea Notarpaolo, Richard Layese, Paolo Magistri, et al.
Lancet (London, England)|January 23, 2022
An educational programme in neonatal intensive care units (SEPREVEN): a stepped-wedge, cluster-randomised controlled trialLaurence Caeymaex, Dominique Astruc, Valérie Biran, et al.
Immunity & Ageing : I & A|December 28, 2024
CD57<sup>+</sup> EMRA CD8<sup>+</sup> T cells in cancer patients over 70: associations with prior chemotherapy and response to anti-PD-1/PD-L1 therapyCécile Gonnin, Michelle Leemans, Florence Canoui-Poitrine, et al.
American Journal of Hematology|September 7, 2019
Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-rituxSamuel Deshayes, Mehdi Khellaf, Anissa Zarour, et al.
European Heart Journal. Acute Cardiovascular Care|October 11, 2021
Diuretic vs. placebo in intermediate-risk acute pulmonary embolism: a randomized clinical trialPascal Lim, Clément Delmas, Olivier Sanchez, et al.
Intensive Care Medicine|August 22, 2018
Clinical spectrum and short-term outcome of adult patients with purpura fulminans: a French multicenter retrospective cohort studyDamien Contou, Romain Sonneville, Florence Canoui-Poitrine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2018
Long-term Quality of Life in Adult Patients Surviving Purpura Fulminans: An Exposed-Unexposed Multicenter Cohort StudyDamien Contou, Florence Canoui-Poitrine, Rémi Coudroy, et al.
Journal of Viral Hepatitis|November 1, 2018
Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohortSegolene Brichler, Pierre Nahon, Fabien Zoulim, et al.
Journal of Hepatology|July 3, 2020
Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV statusEtienne Audureau, Fabrice Carrat, Richard Layese, et al.
Hepatology (Baltimore, Md.)|June 28, 2016
Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir)Nathalie Ganne-Carrié, Richard Layese, Valérie Bourcier, et al.
Pageof 6